Zhengxi Bio

Zhengxi Bio is a hard-tech enterprise specializing in membrane protein antibodies. It continuously develops clinical products around flow fluorescence detection, immunohistochemistry detection, and multi-omics detection, as well as upstream reagent raw materials and third-party terminal special inspections. In the fields of flow cytometry and multi-omics antibody raw materials and reagents, it has achieved domestic substitution, independently developing more than 200 types of multi-omics membrane protein antibody raw materials and solving key bottleneck problems. The domestic bioreagent market has long been monopolized by imports, highlighting the importance of localizing the supply chain. With product performance on par with imported brands, Zhengxi Bio is expected to accelerate the process of domestic substitution in this field and change the competitive landscape. The company's core product, membrane surface flow fluorescence antibodies, overcomes key upstream technical bottlenecks in the IVD industry chain and has clear market demand and opportunities for domestic substitution. With the rise and popularity of immunotherapy, the flow fluorescence detection platform serves as an important analytical tool in immunotherapy, participating in the entire process from R&D preparation characterization, efficacy prediction, to post-medication monitoring.